FDA Inspection 1074257 — Allotex, Inc.
The FDA completed an inspection of Allotex, Inc. on November 8, 2018 in Boston, MA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- November 8, 2018
- Fiscal Year
- 2019
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Boston, MA (United States)